These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29103527)

  • 1. Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges.
    Douroumis D; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():1-2. PubMed ID: 29103527
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs).
    Tan D; Loots L; Friščić T
    Chem Commun (Camb); 2016 Jun; 52(50):7760-81. PubMed ID: 27185190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques.
    Pindelska E; Sokal A; Kolodziejski W
    Adv Drug Deliv Rev; 2017 Aug; 117():111-146. PubMed ID: 28931472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cocrystals in pharmaceutical science.
    Shan N; Zaworotko MJ
    Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
    Almarsson Ö; Peterson ML; Zaworotko M
    Pharm Pat Anal; 2012 Jul; 1(3):313-27. PubMed ID: 24236844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting crystallization of hydrates.
    Tian F; Qu H; Zimmermann A; Munk T; Jørgensen AC; Rantanen J
    J Pharm Pharmacol; 2010 Nov; 62(11):1534-46. PubMed ID: 21039539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced methodologies for cocrystal synthesis.
    Douroumis D; Ross SA; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():178-195. PubMed ID: 28712924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Quality Control of Pharmaceutical Cocrystals.
    Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
    Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lisbon Supramolecular Green Story: Mechanochemistry towards New Forms of Pharmaceuticals.
    Ferreira da Silva JL; Minas da Piedade MF; André V; Domingos S; Martins ICB; Duarte MT
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.
    Ross SA; Lamprou DA; Douroumis D
    Chem Commun (Camb); 2016 Jul; 52(57):8772-86. PubMed ID: 27302311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals.
    Aitipamula S; Bolla G
    Mol Pharm; 2024 Jul; 21(7):3121-3143. PubMed ID: 38814314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Polymorphism and Cocrystallization of Active Pharmaceutical Ingredients Using Vibrational Spectroscopic Techniques.
    Du Y; Xue J
    Curr Pharm Des; 2016; 22(32):4917-4928. PubMed ID: 27464725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical cocrystals: the coming wave of new drug substances.
    Brittain HG
    J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical cocrystals: along the path to improved medicines.
    Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
    Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Perspective on the Permeability of Cocrystals/Organic Salts of Oral Drugs.
    Samie A; Alavian H
    Mol Pharm; 2024 Oct; 21(10):4860-4911. PubMed ID: 39284012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Translational Development of Pharmaceutical Cocrystals.
    Kale DP; Zode SS; Bansal AK
    J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of pharmaceutical cocrystals as intellectual property.
    Trask AV
    Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.